New Technology to Revolutionize Cancer Treatment
Immunotherapy has transformed cancer treatment by utilizing the body’s immune system to combat cancer cells. However, the personalized nature of these therapies leads to high costs and delays in treatment. To address these challenges, UCLA researchers have developed a new method to enhance immune cells known as iNKT cells for a universal cancer treatment. This breakthrough technology, detailed in a recent study published in Nature Biotechnology, aims to make cell therapies more affordable and accessible. Senior author Lili Yang highlights the significance of this advancement and the potential for a clinical trial. The research team successfully engineered iNKT cells to target various cancers, showcasing their effectiveness. With plans to progress to human trials for multiple myeloma and ovarian cancer, this innovation could pave the way for more widespread and affordable cancer immunotherapy.
